TIBER CREEK GROUP for AMGEN INC
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Medicare Part B reimbursement and coding, issues related to pharmaceutical pricing and transparency.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL GONZALEZ | — |
| JAMES HEIMBACH | — |
| JONATHON JONES | — |
Health Issues HCR
S. 469 Affordable and Safe Prescription Drug Importation Act, H.R. 1245 Affordable and Safe Prescription Drug Importation Act, issues related to biosimilars and biosimilars coding. S 934 - FDARA, HR1409 - FDRA, S1348 - SPIKE Act of 2017. S.1519, the National Defense Authorization Act for 2018, Sec 706, Modification of cost-sharing requirements for the TRICARE Pharmacy Benefits Program. S 1827, The Keep Kids Insurance Dependable and Secure (KIDS) Act of 2017
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL GONZALEZ | — |
| JAMES HEIMBACH | — |
| JONATHON JONES | — |
| LINDSEY LEDWIN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.